<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-9190982563308200791</id><updated>2011-09-03T03:55:37.606-07:00</updated><title type='text'>February 2008 Archive of www.icuroom.net</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>29</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-6208620541863759497</id><published>2008-02-29T08:25:00.000-08:00</published><updated>2008-02-29T08:29:19.021-08:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday February 29, 2008&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;After successful completion of Transjugular Intrahepatic Porto-systemic Shunt (TIPS) for variceal bleeding - hepatic encephalopathy __________ ?&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;A) tends to get better&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;B) tends to get worse&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;C) It has nothing to do with TIPS&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Answer is B&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Hepatic encephalopathy tends to get worse after successful completion of TIPS as due to shunting, blood flow to the liver is reduced, which might result in increase toxic substances reaching the brain without being metabolized first by the liver. It can be treated medically such as diet, lactulose or by narrowing of the shunt by insertion of a reducing stent.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a class="l" href="http://www.psic.info/hepatic_encephalopathy.pdf"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Treatment for hepatic encephalopathy: tips from TIPS?&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Journal of Hepatology 42 (2005) 626–628&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=12061205&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Hepatic encephalopathy after TIPS-- retrospective study&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Vnitr Lek. 2002 May;48(5):390-5&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://radiology.rsnajnls.org/cgi/content/full/212/2/411" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;TIPS for Prevention of Recurrent Bleeding in Patients with Cirrhosis: Meta-analysis of Randomized Clinical Trials &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="color:#003333;"&gt;- Radiology. 1999;212:411-421&lt;/span&gt; &lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-6208620541863759497?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/6208620541863759497/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=6208620541863759497' title='41 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6208620541863759497'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6208620541863759497'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/friday-february-29-2008-q-after.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>41</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1007968486009450277</id><published>2008-02-28T14:10:00.000-08:00</published><updated>2008-02-28T14:21:18.692-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday February 28, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Critical Care Rounds&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Critical Care Rounds is now available on line.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Critical Care Rounds is derived from recent Rounds presented at participating hospitals across Canada in association with The Canadian Critical Care Society.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Website is &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.criticalcarerounds.ca/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;www.criticalcarerounds.ca&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/div&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Full archive can be found &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.criticalcarerounds.ca/cgi-bin/templates/body/archives.cfm?displaySectionID=456" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Latest topic is&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;a href="http://www.criticalcarerounds.ca/crus/critcareng_042006.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#660000;"&gt;Outcomes, Cost, and Caregiver Burden in the Acute Respiratory Distress Syndrome (ARDS)&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#003333;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#003333;"&gt;Previous topics include&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.criticalcarerounds.ca/crus/critcareng_032006.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#660000;"&gt;Noninvasive Positive Pressure Ventilation in Critically Ill Patients: The Winds of Change?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.criticalcarerounds.ca/crus/critcareng_022006.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#660000;"&gt;Early Determination of Prognosis in Traumatic Brain Injury: Beyond the Glasgow Coma Scale&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.criticalcarerounds.ca/crus/critcareng_042005.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#660000;"&gt;Initial Evaluation and Management of Severe Community-Acquired Pneumonia&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1007968486009450277?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1007968486009450277/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1007968486009450277' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1007968486009450277'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1007968486009450277'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/thursday-february-28-2008-critical-care.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1804238627505790124</id><published>2008-02-27T08:47:00.000-08:00</published><updated>2008-02-27T08:49:58.804-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday February 27, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Ventilation during CPR - dangers of 'over-bagging'&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Per new ACLS guidelines, the rescuer should deliver a tidal volume sufficient to produce chest rise (approximately 6 to 7 mL/kg or 500 to 600 mL) over 1 second with 8 to 10 breaths per minute.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The standard ventilation bag used in adult ICUs have capacity of 1600 ml ! and over enthuisatic bagging can lead to further deterioration of cardio-pulmonary status, particulary when ETT is already in place, where all tidal volume gets directly delivered to lungs. It may cause further decrease in cardiac output.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;In case of face-mask ventilation, unrealized effect is over gastric inflation leading to regurgitation and aspiration. Moreover, gastric inflation elevate the diaphragm, restrict lung movement and decrease respiratory system compliance.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Sometime its preferable to do one hand bag ventilation rather than two hand ventilation to avoid 'over bagging'.  Depending on hand size, grip strength, height and weight tidal volumes delivered by two hands significantly greater than those delivered by one hand.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to abstract / article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/112/24_suppl/IV-51" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Part 7.1: Adjuncts for Airway Control and Ventilation&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Circulation. 2005;112:IV-51 – IV-57&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://ajcc.aacnjournals.org/cgi/content/abstract/2/6/467" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Comparison of tidal volumes obtained by one-handed and two-handed ventilation techniques&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, American Journal of Critical Care, Vol 2, Issue 6, 467-473&lt;/span&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1804238627505790124?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1804238627505790124/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1804238627505790124' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1804238627505790124'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1804238627505790124'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/wednesday-february-27-2008-ventilation.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8299381092895515456</id><published>2008-02-26T09:14:00.000-08:00</published><updated>2008-02-26T09:18:57.201-08:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday February 26, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Effect of PEEP on the incidence of aspiration in mechanically ventilated patients&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;See this interesting study to test the effects of PEEP (positive end expiratory pressure) on the leakage of fluid around cuffs of different tracheal tubes, in mechanically ventilated patients and in a benchtop model.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Patients:&lt;/span&gt; 40 patients recovering in the intensive care unit distributed in 2 groupswith 2 different types of ETT &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.nellcor.com/prod/Product.aspx?S1=AIR&amp;amp;S2=&amp;amp;id=120" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Hi-Lo tubes&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; and &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.tycohealth-ece.com/files/d0004/ty_1ss9d2.pdf" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;SealGuard tubes&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; (SG group)&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Interventions:&lt;/span&gt; Following steps applied&lt;br /&gt;&lt;ol&gt;&lt;li&gt;Immediately after intubation and cuff inflation with 30 cm H2O, Evans blue was applied onto the cephalic surface of the tracheal tube cuff&lt;/li&gt;&lt;li&gt;A 5-cm H2O positive expiratory pressure was used during the first 5 hrs of stay, and thereafter it was removed &lt;/li&gt;&lt;li&gt;Leakage was also tested in vitro with the same tracheal tubes with incremental level of PEEP&lt;/li&gt;&lt;li&gt;At 1 hr, 5 hrs, and thereafter hourly until 12 hrs, bronchoscopy was used to test the presence of dye on the trachea caudal to the cuff&lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results:&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt; At the fifth hour, two patients of the HL group failed the test&lt;/li&gt;&lt;li&gt;One hour after positive expiratory pressure removal, all subjects in group HL exhibited a dyed lower trachea &lt;/li&gt;&lt;li&gt;One patient in group SG presented a leak at the eighth hour, and at the 12th hour 17 had leak&lt;/li&gt;&lt;li&gt;In vitro, the same level of PEEP delayed the passage of dye&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Conclusions:&lt;/span&gt; Authors concluded that 5 cm H2O positive expiratory pressure was effective in delaying the passage of fluid around the cuffs of tracheal tubes both in vivo and in vitro.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#003333;"&gt;&lt;span style="font-size:78%;"&gt;Reference: click to abstract / article&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200802000-00006.htm;jsessionid=HDQhwGBp8pFbtMbgmNMgW2DJtsYTGG1gj9J42lBTwrn9LG2sQfCK!1253064403!181195628!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Effect of positive expiratory pressure and type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an intensive care unit&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; , Critical Care Medicine. 36(2):409-413, February 2008&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8299381092895515456?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8299381092895515456/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8299381092895515456' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8299381092895515456'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8299381092895515456'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/tuesday-february-26-2008-effect-of-peep.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-2537111509819444900</id><published>2008-02-25T12:23:00.000-08:00</published><updated>2008-02-25T12:26:33.535-08:00</updated><title type='text'></title><content type='html'>&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday February 25, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Improving delirium in ICU via education !&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;strong&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;In a recent study, Fifty ICU nurses from two different hospitals (university medical and community teaching) evaluated an ICU patient for pain, level of sedation and presence of delirium before-and-after an educational intervention. The same patient was concomitantly, but independently, evaluated by a validated judge who acted as the reference standard in all cases. The education consisted of: &lt;/span&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;ol&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;two script concordance case scenarios &lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;a slide presentation regarding scale-based delirium assessment, and &lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;two further cases&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ol&gt;&lt;div align="left"&gt; &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results&lt;/span&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;Nurses clinical recognition of delirium was poor in the before education period as only 24% of nurses reported the presence or absence of delirium and only 16% were correct compared to the judge. &lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;After education, the number of nurses able to evaluate delirium using any scale (12 vs. 82%) and use it correctly (8 vs. 62%) increased significantly&lt;/span&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;span style="color:#000000;"&gt;While judge-nurse agreement (Spearman rho) for the presence of delirium was similar between the pre and post education periods&lt;/span&gt;&lt;br /&gt; &lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Conclusions:&lt;/span&gt; &lt;span style="color:#000000;"&gt;A simple composite educational intervention incorporating script concordance theory improves the capacity for ICU nurses to screen for delirium nearly as well as experts&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt; &lt;/div&gt;&lt;div align="left"&gt;&lt;span style="color:#003333;"&gt;Editors' note:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Delirium in general is a very common problem; around 20% patients admitted to hospital have delirium. Delirium is commonly occurs in critically ill patient, especially who have other co-morbidities and have prolonged stay in the ICU. The treatment is difficult to provide, although easy to write: treat the underlying cause. Following site has a lot of information about delirium in icu including videos and other links:&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;"&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;a href="http://www.icudelirium.org/"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;www.icudelirium.org&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;div align="left"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to abstract / article&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;a title="http://ccforum.com/content/pdf/cc6793.pdf&amp;#13;&amp;#10;&amp;#9;&amp;#9;&amp;#9;&amp;#9;" href="http://ccforum.com/content/pdf/cc6793.pdf%0D%0A%09%09%09%09%09" target="_blank" rel="nofollow"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Combined Didactic and Scenario-Based Education Improves the Ability of ICU Staff to Recognize Delirium at the Bedside&lt;/span&gt;&lt;/a&gt;&lt;a title="http://ccforum.com/content/pdf/cc6793.pdf&amp;#13;&amp;#10;&amp;#9;&amp;#9;&amp;#9;&amp;#9;" href="http://ccforum.com/content/pdf/cc6793.pdf%0D%0A%09%09%09%09%09" target="_blank" rel="nofollow"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;,  &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Critical Care, 2008 12:R19 ( 21 February 2008) - open access article - pdf file&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-2537111509819444900?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/2537111509819444900/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=2537111509819444900' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/2537111509819444900'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/2537111509819444900'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/monday-february-25-2008-improving.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-818854001686624010</id><published>2008-02-24T12:29:00.000-08:00</published><updated>2008-02-23T12:30:31.548-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday February 24, 2008&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Clonidine and Bradycardia !&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Clonidine is a alpha adrenergic agonist with sympatholytic activity and has been used for various clinical indications beside blood pressure control including treatment for migraines, menopausal complaints, narcotic and alcohol withdrawal symptoms, spasticity after spinal cord injury, attention-deficit hyperactivity disorder as well as rate control for atrial fibrillation.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Mechanism of action:&lt;/span&gt; Symptomatic bradycardia is a side effect of clonidine which many times go ignored. Clonidine's central effect results in decreased sympathetic outflow and enhanced vagal tone, lowering blood pressure and heart rate. This also cause side effects of drowsiness, lethargy and dry mouth. Clonidine acts peripherally within the heart to inhibit norepinephrine release, contributing to further reductions in heart rate.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Risk factors:&lt;/span&gt; Patients at higher risk for clonidine-induced bradycardia seem to be those with an already-diseased conduction system, renal failure, high doses of clonidine, concomitant therapy with medications known to cause bradycardia or heart block, (eg, beta-blockers, verapamil, diltiazem, digoxin). &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Treatment:&lt;/span&gt; For severe, symptomatic bradycardia, atropine can be used. For refractory symptomatic cases, isoproterenol, epinephrine, dopamine, and pacing may be required&lt;/span&gt;&lt;/strong&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-818854001686624010?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/818854001686624010/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=818854001686624010' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/818854001686624010'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/818854001686624010'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/sunday-february-24-2008-clonidine-and.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1449529481304697310</id><published>2008-02-23T19:19:00.000-08:00</published><updated>2008-02-23T12:28:52.714-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday February 23, 2008&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;One good practice !&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Beauty of Critical Care lies in details !&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;To get less erroneous or in other words consistent lab results is to place a policy for procedure for drawing blood samples from indwelling lines.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;If using a multi lumen (eg triple lumen catheter) line for blood drawing, one port of the line should be identified and labelled as the blood withdrawal port and used exclusively for blood drawing if possible.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Definitely, blood should not be drawn from TPN infusion and preferably not from pressor infusions to avoid the  hypotensive episodes.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Another important and many time forgotten part - if line is flushed with Heparin, it should be documented in medication list (mostly call MAR in USA).&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1449529481304697310?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1449529481304697310/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1449529481304697310' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1449529481304697310'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1449529481304697310'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/saturday-february-23-2008-one-good.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-6035926861478576534</id><published>2008-02-22T10:02:00.000-08:00</published><updated>2008-02-22T10:04:34.414-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday February 22, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;5-point auscultation post intubation&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;As soon as intubation is performed, it is a good habit to listen for breath sounds, though not reliable but still provide extra confirmation of proper placement particularly when end-tidal carbon dioxide device is not available.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;One recommended method is 5-point auscultation post intubation. Listen over&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;right lateral lung field, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;left lateral lung field,&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;the left axilla, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;the right axilla, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Over stomach to make sure no air movement should occur over the stomach.&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Tracheal intubation - Anaesthesia &amp;amp; Intensive Care Medicine, Volume 8, Issue 9, Pages 347-351&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-6035926861478576534?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/6035926861478576534/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=6035926861478576534' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6035926861478576534'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6035926861478576534'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/friday-february-22-2008-5-point.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-5531021164159430664</id><published>2008-02-21T09:36:00.000-08:00</published><updated>2008-02-21T09:37:34.740-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday February 21, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Noninvasive Ventilation before Intubation of Hypoxic Patients ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;If enough denitrogenation is not provided critically ill patients are predisposed to quick desaturation during intubation. We found this new approach before intubation in hypoxic  patients.&lt;br /&gt;&lt;br /&gt;Prospective randomized study was performed, with 2 groups, the control (n = 26) and NIV (n = 27). Preoxygenation was performed, before a rapid sequence intubation, for a 3-min period using a nonrebreather bag-valve mask (control group) or pressure support ventilation delivered by an ICU ventilator through a face mask (NIV group) according to the randomization.&lt;br /&gt;&lt;br /&gt;The control (n = 26) and NIV (n = 27) groups were similar in terms of age, disease severity, diagnosis at admission, and pulse oxymetry values (SpO2) before preoxygenation.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results:&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;At the end of preoxygenation, SpO2 was higher in the NIV group as compared with the control group (98 ± 2 vs. 93 ± 6%,) &lt;/li&gt;&lt;li&gt;During the intubation procedure, the lower SpO2 values were observed in the control group (81 ± 15 vs. 93 ± 8%) &lt;/li&gt;&lt;li&gt;Twelve (46%) patients in the control group and two (7%) in the NIV group had an SpO2 below 80% &lt;/li&gt;&lt;li&gt;Five minutes after intubation, SpO2 values were still better in the NIV group as compared with the control group (98 ± 2 vs. 94 ± 6%) &lt;/li&gt;&lt;li&gt;Regurgitations (n = 3; 6%) and new infiltrates on post-procedure chest X ray (n = 4; 8%) were observed with no significant difference between groups&lt;br /&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; For the intubation of hypoxemic patients, preoxygenation using NIV is more effective at reducing arterial oxyhemoglobin desaturation than the usual method.&lt;/p&gt;&lt;p&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;Reference: click to get abstract /article&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;a href="http://ajrccm.atsjournals.org/cgi/content/abstract/174/2/171" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Noninvasive Ventilation Improves Preoxygenation before Intubation of Hypoxic Patients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 171-177, (2006)&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-5531021164159430664?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/5531021164159430664/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=5531021164159430664' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5531021164159430664'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5531021164159430664'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/thursday-february-21-2008-noninvasive.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8951193035888031387</id><published>2008-02-20T15:11:00.000-08:00</published><updated>2008-02-20T15:13:55.060-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday February 20, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Minocycline in Acute Ischemic Stroke ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Minocycline is a second-generation derivative of tetracycline that has been shown to have a beneficial neuroprotective effect in animal models of MS (multiple sclerosis), Parkinson's disease, Huntington's disease, and ALS. Also, here has been  evidence of minocycline's ability to improve outcomes in an animal model of stroke. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Proposed mechanism of action:&lt;/span&gt;  Proposed mechanisms of action in minocycline include its antiinflammatory effect, reduction of microglia activation, matrix metalloproteinase reduction, nitric oxide production, and inhabitation of apoptotic cell death.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Clinical study:&lt;/span&gt;  This was an open-label clinical trial, although the evaluator was blinded. &lt;br /&gt;&lt;br /&gt;&lt;em&gt;Number (n)&lt;/em&gt; =  152 patients who suffered acute ischemic strokes&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Mean age&lt;/em&gt; =  67 years&lt;br /&gt;&lt;br /&gt;74 patients were randomized to receive 200 mg per day of minocycline orally for five days with a therapeutic window of six to 24 hours after onset of stroke. 77 patients were randomized to receive placebo in the same time window.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The primary outcome:&lt;/em&gt;  was the NIH Stroke Scale score 90 days after admission to the study.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results:&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;At day 90, NIH Stroke Scale scores were significantly lower for minocycline-treated subjects compared to placebo treated patients&lt;/li&gt;&lt;li&gt;This difference was already statistically significant by day seven and day 30 of the trial&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; The investigators conclude that patients with acute stroke had significantly better outcome with minocycline treatment compared to placebo.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/p&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;Reference: click to get abstract /article&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://www.neurology.org/cgi/content/abstract/69/14/1404" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Minocycline Treatment in Acute Stroke:&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; An Open-Label, Evaluator-Blinded Study. Neurology; 2007; 69 (October 2): 1404-1410&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8951193035888031387?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8951193035888031387/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8951193035888031387' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8951193035888031387'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8951193035888031387'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/wednesday-february-20-2008-minocycline.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8319487357260588446</id><published>2008-02-19T21:34:00.000-08:00</published><updated>2008-02-18T21:37:02.861-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday February 19, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Clinical Institute Withdrawal Assessment for Alcohol—Revised (CIWA-Ar)&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The most objective tool to assess the severity of alcohol withdrawal is the Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar). Score consists of 10 items and can be performed in 5 minutes at the bedside. The questions include regarding following 10 items &lt;/span&gt;&lt;br /&gt;&lt;ol&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;nausea and vomiting, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;anxiety, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;tremor, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;sweating, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;auditory disturbances, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;visual disturbances, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;tactile disturbances, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;headache, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;agitation, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;clouding of sensorium&lt;/span&gt;&lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;0 to 7 points are assigned for each item except for the last item, which is assigned 0-4 points, with a total possible score of 67&lt;/em&gt;.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The CIWA-Ar is not copyrighted and may be reproduced freely. Patients scoring less than 10 do not usually need additional medication for withdrawal.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;CIWA-Ar has been demonstrated to have high reliability, reproducibility, and validity. Careful and frequent monitoring with the CIWA-Ar is clinically found to be very helpful.&lt;br /&gt;&lt;br /&gt;You can view the full survey &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://images2.clinicaltools.com/images/pdf/ciwa-ar.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt; &lt;/span&gt;(pdf)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8319487357260588446?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8319487357260588446/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8319487357260588446' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8319487357260588446'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8319487357260588446'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/tuesday-february-19-2008-clinical.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-6095277441690539601</id><published>2008-02-18T16:08:00.000-08:00</published><updated>2008-02-18T16:10:16.560-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday February 18, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Vancomycin worse for MSSA ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Vancomycin is widely used for empirical treatment of patients with suspected gram-positive bacteremia, even if its not MRSA. One Recent large case-control study from korea showed poorer outcomes for vancomycin than for β-lactams in patients with methicillin-susceptible (MSSA) bacteremia.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;In a retrospective cohort study (n=294), patients who received vancomycin or teicoplanin therapy had a significantly higher S. aureus related mortality rate than did those with -lactam treatment.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;In cohort study, S. Aureus Bateremia (SAB)-related mortality in patients with vancomycin treatment (37%, 10/27) was significantly higher than that in those with beta-lactam treatment (18%, 47/267) (P=0.02)&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;strong&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;In the case-control study using the objective matching scoring system and the propensity score system, SAB-related mortality in case patients was 37% (10/27) and in control patients 11% (6/54) (P &lt;&gt;&lt;/strong&gt; &lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; &lt;span style="color:#000000;"&gt;The  available evidence strongly  suggest a switch from empirically started vancomycin to a -lactam as soon as MRSA has been ruled out.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;References:  click to get abstract/articles&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://aac.asm.org/cgi/content/abstract/52/1/192" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, Antimicrobial Agents and Chemotherapy, January 2008, p. 192-197&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-6095277441690539601?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/6095277441690539601/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=6095277441690539601' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6095277441690539601'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/6095277441690539601'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/monday-february-18-2008-vancomycin.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-3673076657143516208</id><published>2008-02-17T08:24:00.000-08:00</published><updated>2008-02-17T08:26:58.575-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday February 17, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Clostridium difficile-Associated Disease in the ICU Setting&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Recently one retrospective observational, cohort study was performed to analyse 30-Day mortality for Clostridium difficile associated disease (CDAD) in the ICU Setting. &lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt; &lt;br /&gt;278 patients with CDAD admitted to an ICU were identified over a 2-year period.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;The overall 30-day mortality rate was 36.7% (n = 102), Independent predictors for 30-day mortality were septic shock, ward-to-ICU transfer and increasing APACHE II scores &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;The attributable mortality associated with CDAD was estimated to be 6.1%&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;CDAD was associated with an excess ICU length of stay (2.2 days) &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;CDAD was associated with an excess hospital length of stay (4.5 days)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#003333;"&gt;Editors' note:&lt;/span&gt; &lt;em&gt;C.diff is well known to intensivists. Objective of above post is to reinforce the high suspicion towards C. diff.&lt;/em&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/articles&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:78%;"&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;1. &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/132/2/418" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Analysis of 30-Day Mortality for Clostridium difficile-Associated Disease in the ICU Setting&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest. 2007; 132:418-424&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-3673076657143516208?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/3673076657143516208/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=3673076657143516208' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/3673076657143516208'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/3673076657143516208'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/sunday-february-17-2008-clostridium.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8077924009211848807</id><published>2008-02-16T10:25:00.000-08:00</published><updated>2008-02-16T10:26:13.290-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday February 16, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Synergistic agents for Daptomycin&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Daptomycin is the first approved member of a new class of antibiotics, namely the cyclic lipopeptides. Daptomycin has rapid bactericidal activity against Gram-positive pathogens. &lt;br /&gt;&lt;br /&gt;Daptomycin was shown to be not inferior to antimicrobial standard therapy for Staphylococcus aureus bacteremia and right-sided endocarditis.&lt;br /&gt;&lt;br /&gt;This is of interest to know that there is a marked synergy between daptomycin and both &lt;em&gt;rifampin and ampicillin&lt;/em&gt; against vancomycin-resistant enterococci (VRE) - despite high-level of ampicillin resistance alone. Also most strains of MRSA are found to have synergism between daptomycin and &lt;em&gt;oxacillin &lt;/em&gt;despite it shows resistant alone to oxacillin (as in case of  ampicillin in VRE). &lt;em&gt;Ampicillin-sulbactam, ticarcillin-clavulanate, or piperacillin-tazobactam&lt;/em&gt; showed synergy comparable to or greater than daptomycin with oxacillin.&lt;br /&gt;&lt;br /&gt;It may be of clinical benefit to add synergistic agents while using Daptomycin as it is a 'concentration-dependent' drug.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;References: click to get abstract/articles&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://aac.asm.org/cgi/content/abstract/48/8/2871" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Synergy of Daptomycin with Oxacillin and Other ß-Lactams against Methicillin-Resistant Staphylococcus aureus &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Antimicrobial Agents and Chemotherapy, August 2004, p. 2871-2875, Vol. 48, No. 8&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://content.karger.com/produktedb/produkte.asp?doi=109868" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Daptomycin: A Review 4 Years after First Approval&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Pharmacology 2008;81:79-91&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8077924009211848807?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8077924009211848807/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8077924009211848807' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8077924009211848807'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8077924009211848807'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/saturday-february-16-2008-synergistic.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1761164390424568432</id><published>2008-02-15T10:01:00.000-08:00</published><updated>2008-02-15T10:04:06.438-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday February 15, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;THAM &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Introduction;&lt;/span&gt; &lt;span style="color:#000000;"&gt;In patients with acute respiratory distress syndrome (ARDS), permissive hypercapnia is a strategy to decrease airway pressures to prevent ventilator-induced lung damage by lowering tidal volumes and tolerating higher arterial carbon dioxide tension. A pure respiratory acidosis generally does not require alkali therapy. Alkali therapy is indicated for either a metabolic acidosis or a mixed acidosis. The choice of buffer is based on type of acidosis, cardiorespiratory status, and lung mechanics.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Problem with NaHCO3:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Slow infusions of NaHCO3 can be used to treat non-anion gap metabolic acidosis and some forms of increased anion gap acidosis. But using NaHCO3 to treat type A (hypoxia-related) lactic acidosis can be hazardous, particularly under conditions of hypoxemia, inadequate circulation, and limited alveolar ventilation.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;THAM:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Under above circumstances, THAM is the preferable buffer because it does not increase PaCO2 and is excreted by the kidneys. Tromethamine (THAM) is a sodium-free alkalinizing agent that acts as a hydrogen ion (proton) acceptor. It is a weak base that combines with hydrogen ions from carbonic acid to form bicarbonate and cationic buffer. Administration of tromethamine decreases hydrogen ion concentration, which results in a decrease in carbon dioxide concentrations and an increase in bicarbonate concentrations. The administration of Tham also increases urine output through osmotic diuresis. Excretion of electrolytes and CO2 is also increased. Urine pH is raised along with the excretion of electrolytes.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Usual Dose:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Dose in ml's of 0.3M THAM = (1.1) (Wt. in Kg) (normal HCO3 – Pt’s HCO3)&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;OR&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/div&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Dose in ml’s of 0.3M THAM = body wt in kg X base deficit in MEq/L x 1.1&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Total dose should be administered over a period not less than 1 hour via central line..3M THAM solution is available as premix and is contra-indicated in renal failure, anuria and hyperkalemia. It may cause transient hypoglycemia and respiratory depression.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1761164390424568432?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1761164390424568432/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1761164390424568432' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1761164390424568432'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1761164390424568432'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/friday-february-15-2008-tham.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-3063871574265384885</id><published>2008-02-14T19:55:00.000-08:00</published><updated>2008-02-15T10:04:32.340-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday February 14, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Alinia(Nitazoxanide) in Clostridium Difficile Colitis &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Beside Vancomycin and Flagyl, an adjuvant treatment may be use in C. diff. Colitis with Alinia (Nitazoxanide), 500 mg twice daily. Actually, emerging literature is showing it to be a promising treatment in cases where metronidazole fails to eradicate C.diff.&lt;br /&gt;&lt;br /&gt;Nitazoxanide is an FDA approved drug to treat parasitic diseases of the gastrointestinal tract. It is very widely use as an antiprotozoal agent in pediatric patients with diarrhea. The drug acts by blocking and interfering with anaerobic metabolic pathways, and has been shown to have excellent activity against C. difficile. Limited but postive literature shows its value in C.dif. colitis both as an adjuvant as well as in metronidazole failed C.diff. colitis.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://jac.oxfordjournals.org/cgi/content/abstract/59/4/705"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Clostridium difficile colitis that fails conventional metronidazole therapy: response to &lt;/span&gt;&lt;/a&gt;&lt;a href="http://jac.oxfordjournals.org/cgi/content/abstract/59/4/705"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;nitazoxanide&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, Journal of Antimicrobial Chemotherapy 2007 59(4):705-710&lt;br /&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://clinicaltrials.gov/ct2/show/NCT00304356" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - clinicaltrials.gov&lt;br /&gt;&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90054"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;In Vitro and In Vivo Activities of Nitazoxanide against &lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90054"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Clostridium difficile&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Antimicrob Agents Chemother. 2000 September; 44(9): 2254–2258.&lt;br /&gt;&lt;br /&gt;4. &lt;/span&gt;&lt;a class="css_title" title="Show full info about paper" href="http://lib.bioinfo.pl/pmid:16838229" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Nitazoxanide for the treatment of Clostridium difficile colitis.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; , Clin Infect Dis. 2006 Aug 15;43 (4):421-7 16838229&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-3063871574265384885?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/3063871574265384885/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=3063871574265384885' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/3063871574265384885'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/3063871574265384885'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/thursday-february-14-2008.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-251648800577756278</id><published>2008-02-13T08:24:00.000-08:00</published><updated>2008-02-13T08:27:01.268-08:00</updated><title type='text'></title><content type='html'>&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday February 13, 2008&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt; Name few drugs which can be use in VRE (Vancomycin-resistant  enterococcus) Meningitis ?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;New growing literature is showing that IV and even PO Zyvox (linezolid) should be the first line of treatment in VRE Meningitis as it has a very good penetration in CSF.&lt;br /&gt;&lt;br /&gt;Other viable choices are chloramphenicol, Ampicillin (or penicillin) and Synercid (Quinupristin/dalfopristin).&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;Reference: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200112000-00023.htm;jsessionid=HyMT1xL1qv2JRvGL2J6NJkd7SRPpZzvB8N5rjV72P6zlt0RYyBQK!-809317659!181195629!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;: Case report and review of the literature Critical Care Medicine. 29(12):2383-2385, December 2001.&lt;/span&gt;&lt;br /&gt;  &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-251648800577756278?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/251648800577756278/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=251648800577756278' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/251648800577756278'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/251648800577756278'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/wednesday-february-13-2008-q-name-few.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-9162314537432886881</id><published>2008-02-12T11:05:00.000-08:00</published><updated>2008-02-12T11:08:21.925-08:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday February 12, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Precedex® (dextromedetomidine) - better?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Precedex is now a commonly used drip in ICUs due to its simultaneous anxiolytic, anesthetic, hypnotic, and analgesic properties and moreover it does not depress respiration. But still cost is a major concern to prescribe this medicine.&lt;br /&gt;&lt;br /&gt;A recent study published in JAMA&lt;span style="color:#660000;"&gt; &lt;/span&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="color:#660000;"&gt;1&lt;/span&gt; &lt;/span&gt;found Dexmedetomidine superior to Lorazepam for sedation. Dexmedetomidine induces sedation via different central nervous system receptors than the benzodiazepine drugs and may lower the risk of acute brain dysfunction. Interestingly, there was no difference in cost.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Design:&lt;/span&gt; It was a double-blind, randomized controlled trial. &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Number:&lt;/span&gt; 106 adult mechanically ventilated medical and surgical ICU patients. Patients were sedated with dexmedetomidine or lorazepam for as many as 120 hours.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Scales used:&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; Richmond Agitation-Sedation Scale (RASS). &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Patients were monitored twice daily for delirium using the Confusion Assessment Method for the ICU (CAM-ICU). &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results :&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;Sedation with dexmedetomidine resulted in more days alive without delirium or coma (median days, 7.0 vs 3.0) &lt;/li&gt;&lt;li&gt;a lower prevalence of coma (63% vs 92%) &lt;/li&gt;&lt;li&gt;Patients sedated with dexmedetomidine spent more time within 1 RASS point of their sedation goal compared with patients sedated with lorazepam (median percentage of days, 80% vs 67%) &lt;/li&gt;&lt;li&gt;The 28-day mortality in the dexmedetomidine group was 17% vs 27% in the lorazepam group  &lt;/li&gt;&lt;li&gt;&lt;em&gt;cost of care was similar between groups&lt;/em&gt; &lt;/li&gt;&lt;li&gt;The 12-month time to death was 363 days in the dexmedetomidine group vs 188 days in the lorazepam group&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt;  In mechanically ventilated ICU patients managed with individualized targeted sedation, use of a dexmedetomidine infusion resulted in more days alive without delirium or coma and more time at the targeted level of sedation than with a lorazepam infusion.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Related previous pearl:&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://jama.ama-assn.org/cgi/content/abstract/298/22/2644" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Regarding Dexmedetomidine (Precedex)&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;Reference: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://jama.ama-assn.org/cgi/content/abstract/298/22/2644" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, The MENDS Randomized Controlled Trial, JAMA. 2007;298(22):2644-2653.&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-9162314537432886881?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/9162314537432886881/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=9162314537432886881' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/9162314537432886881'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/9162314537432886881'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/tuesday-february-12-2008-precedex.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-7191319316946054163</id><published>2008-02-11T15:17:00.000-08:00</published><updated>2008-02-11T15:19:26.588-08:00</updated><title type='text'></title><content type='html'>&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday February 11, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;LMA insertion - an excellent animation video&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;This video is included in our video section&lt;/span&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="373" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/96e46PyARaU&amp;amp;rel=1&amp;amp;border=1"&gt;&lt;param name="wmode" value="transparent"&gt;&lt;embed src="http://www.youtube.com/v/96e46PyARaU&amp;rel=1&amp;border=1" type="application/x-shockwave-flash" wmode="transparent" width="425" height="373"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-7191319316946054163?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/7191319316946054163/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=7191319316946054163' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/7191319316946054163'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/7191319316946054163'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/monday-february-11-2008-lma-insertion.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-5427356973970059067</id><published>2008-02-10T21:46:00.000-08:00</published><updated>2008-02-09T21:50:16.274-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday February 10, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Venous PH&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;During or immediately following CPR, and in hemodynamic shock which PH is more worthwhile to follow ?&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; &lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Venous PH&lt;br /&gt;&lt;br /&gt;During shock state, venous blood is a more accurate reflection of metabolism in tissues. It may be of benefit to follow the trend in venous PH to measure the improvement of shock following CPR and hemodynamic instability.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/315/3/153" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, NEJM, Number 3, Volume 315:153-156, July 17, 1986&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-5427356973970059067?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/5427356973970059067/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=5427356973970059067' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5427356973970059067'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5427356973970059067'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/sunday-february-10-2008-venous-ph-q.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-5183632173749945095</id><published>2008-02-09T21:39:00.000-08:00</published><updated>2008-02-08T21:46:09.194-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday February 9, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Adjuvant treatment in Ethylene Glycol toxicity&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Which 2 very easily available and cost-effective drugs should be added as an adjuvant treatment in Ethylene Glycol toxicity (though mostly forgotten) ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; Thiamine 100 mg IV daily and Pyridoxine 100 mg IV daily&lt;br /&gt;&lt;br /&gt;One of the metabolite of Ethylene Glycol is Glycolic acid which converts into Glycoxylic Acid and remains toxic. Thiamine and Pyridoxine converts Glycoxylic Acid into non-toxic metabolites and decreases long term toxic effects of Ethylene Glycol.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Related previous pearl:&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://february-2007-icuroom.blogspot.com/2007_02_23_archive.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Ethanol drip in Ethylene Glycol toxicity&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://february-2007-icuroom.blogspot.com/2007_02_24_archive.html" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Treating Ethylene Glycol poisoning&lt;/strong&gt; &lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-5183632173749945095?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/5183632173749945095/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=5183632173749945095' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5183632173749945095'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/5183632173749945095'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/saturday-february-9-2008-adjuvant.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1281674288297815767</id><published>2008-02-08T11:13:00.000-08:00</published><updated>2008-02-08T11:14:02.792-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday February 8, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Dialysis and central catheter's diameter !&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Internal diameter of each lumen of dialysis catheter is about twice the diameter of each lumen in a triple-lumen central venous catheter.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Clinical application:&lt;/span&gt; As per Hagen-Poiseuille equation, just 2 fold increase in radius increase flow by 16 fold.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1281674288297815767?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1281674288297815767/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1281674288297815767' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1281674288297815767'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1281674288297815767'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/friday-february-8-2008-dialysis-and.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-1773169406318407545</id><published>2008-02-07T11:34:00.000-08:00</published><updated>2008-02-07T11:38:33.671-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday February 7, 2008&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Sodium Bicarbonate in contrast induced nephropathy (CIN) -  a risk ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sodium Bicarbonate is increasingly being used to prevent contrast induced nephropathy which was based on a small study &lt;span style="font-size:78%;"&gt;(1).&lt;/span&gt; The role of this prophylaxis is being questioned by a recent large retrospective study from Mayo&lt;span style="font-size:78%;"&gt; (2).&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;Groups: &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;ol&gt;&lt;li&gt;&lt;strong&gt;sodium bicarbonate, &lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;N-acetylcysteine, and&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;the combination of sodium bicarbonate with N-acetylcysteine&lt;/strong&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;&lt;em&gt;Contrast nephropathy was defined as postexposure creatinine elevation of 25% or &gt;0.5 mg/dl within 7 days of contrast exposure.&lt;/em&gt;&lt;/p&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Total numbers&lt;/span&gt;:&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt; A total of 11,516 contrast exposures in 7977 patients had creatinine values available for review before and after contrast exposure. &lt;/strong&gt;&lt;/li&gt;&lt;strong&gt;&lt;li&gt;Sodium bicarbonate was used in 268 cases,&lt;/li&gt;&lt;li&gt; N-acetylcysteine was used in 616 cases, and &lt;/li&gt;&lt;li&gt;both agents were used in combination in 221 cases&lt;br /&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Results:  &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Use of sodium bicarbonate alone was associated with an increased risk of contrast nephropathy compared with no treatment &lt;/li&gt;&lt;li&gt;N-acetylcysteine alone and in combination with sodium bicarbonate was not associated with any significant difference in the incidence of contrast nephropathy.&lt;br /&gt;&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Conclusions:&lt;/span&gt; The use of intravenous sodium bicarbonate was associated with increased incidence of contrast nephropathy.&lt;br /&gt;&lt;br /&gt;But also note, recent REMEDIAL trial, showed that the strategy of volume supplementation by sodium bicarbonate plus NAC seems to be superior to the combination of normal saline with NAC in preventing CIN in patients at medium to high risk. &lt;span style="font-size:78%;color:#660000;"&gt;(3)&lt;/span&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Editors' note:&lt;/span&gt; &lt;span style="color:#000000;"&gt;So far, it appears except for adequate hydration, most of the therapies have no consistent track of advantage and results are variable.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/p&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://jama.ama-assn.org/cgi/content/abstract/291/19/2328" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; JAMA 2004; 291:2328-2334.&lt;br /&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://cjasn.asnjournals.org/cgi/content/abstract/3/1/10" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Clin J Am Soc Nephrol 2008; 3:10-18.&lt;br /&gt;&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.106.687152v1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL). A randomized comparison of 3 preventive strategies&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. Circulation 2007; DOI:10.1161/CIRCULATIONAHA.106.687152.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-1773169406318407545?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/1773169406318407545/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=1773169406318407545' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1773169406318407545'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/1773169406318407545'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/thursday-february-7-2008-sodium.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-971915058667691319</id><published>2008-02-06T06:55:00.000-08:00</published><updated>2008-02-06T06:57:40.699-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday February 6, 2008&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;Case:&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;52 year old male is back from cardiac angioplasty with abciximab (ReoPro) infusion. Pre-cath labs were normal. CBC was send per protocol after 4 hours of abciximab infusion and lab call with critical platelet level of 62. Abciximab was stopped and hematology consulted. Hematology advised to restart abciximab !!&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Pseudothrombocytopenia&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Pseudothrombocytopenia is a common phenomenon with patients on abciximab (ReoPro). It is a benign condition and is not a real thrombocytopenia as platelets actually clump in collecting tubes containg EDTA. It is an important diagnosis to make. Diagnosis can be made by reviewing peripheral blood film or drawing blood in citrated or heparinized tube. It is not clear why abciximab cause more EDTA-induced platelet clumping.* EDTA (Ethylenediaminetetraacetic acid) is a commonly used anticoagulant in sampling tubes for blood counts.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=10898416&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; J Am Coll Cardiol. 2000 Jul;36(1):75-83. &lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/101/8/938" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Abciximab-Associated Pseudothrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Circulation. 2000;101:938&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://jcp.bmjjournals.com/cgi/content/abstract/47/7/625" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Journal of Clinical Pathology 1994;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;47:625-6304.&lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/short/329/20/1467" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Pseudothrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Volume 329:1467 Nov. 11, 1993&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-971915058667691319?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/971915058667691319/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=971915058667691319' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/971915058667691319'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/971915058667691319'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/wednesday-february-6-2008-case-52-year.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-2310477019904681365</id><published>2008-02-05T14:46:00.000-08:00</published><updated>2008-02-05T14:48:39.907-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday February 5, 2008&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Can Wernicke's Encephalopathy be iatrogenic in ICU ?&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; Yes, it can be precipitate in any patient by glucose (like D-5, D-10 or D-50) administration who is thiamine deficient. It is not limited to alcoholics and can happen in any nutritionally deficient patient. It is always a good idea to add thiamine in glucose drip in patients who are at risk of Wernicke's Encephalopathy. Disorder was described 25 years ago by Carl Wernicke as a triad of&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;acute mental confusion &lt;/li&gt;&lt;li&gt;ataxia &lt;/li&gt;&lt;li&gt;opthalmoplegia &lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#000000;"&gt;Read a case of Wernicke's encephalopathy. in a non-alcoholic patient with MRI findings &lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://content.nejm.org/cgi/content/full/352/19/e18" target="_blank"&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#000000;"&gt; (Ref.: The New England Journal of Medicine, Kaineg and Hudgins 352 (19): e18, May 12, 2005)&lt;br /&gt;&lt;br /&gt;Also full review article &lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://www.emedicine.com/EMERG/topic642.htm" target="_blank"&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;Wernicke's encephalopathy&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#000000;"&gt; at emedicine.com&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-2310477019904681365?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/2310477019904681365/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=2310477019904681365' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/2310477019904681365'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/2310477019904681365'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/tuesday-february-5-2008-q-can-wernickes.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8588913580924073152</id><published>2008-02-04T09:34:00.000-08:00</published><updated>2008-02-04T20:50:28.068-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday February 4, 2008&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;What to do in case of accidental esophageal intubation !&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;strong&gt;Editors' note:&lt;/strong&gt; &lt;em&gt;&lt;strong&gt;The following video is a practice or opinion of some intensivits but not proved or recommended by clinical trials.&lt;/strong&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;Total video time: 1 minute 24 secs&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="373" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/xmyGDmvNDtw&amp;amp;rel=1&amp;amp;border=1"&gt;&lt;param name="wmode" value="transparent"&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/xmyGDmvNDtw&amp;rel=1&amp;border=1" type="application/x-shockwave-flash" wmode="transparent" width="425" height="373"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8588913580924073152?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8588913580924073152/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8588913580924073152' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8588913580924073152'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8588913580924073152'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/monday-february-4-2008-what-to-do-in.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-8450236713790947463</id><published>2008-02-03T09:23:00.000-08:00</published><updated>2008-02-03T09:41:06.328-08:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday February 3, 2008&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Bimanual Laryngoscopy - BURP !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;One 'trick' to enhance successful intubation is using 'Bimanual Laryngoscopy'.&lt;br /&gt;&lt;em&gt;Its different from cricoid pressure&lt;/em&gt; as explained in video.&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;p&gt;&lt;strong&gt;Its also called &lt;span style="color:#000066;"&gt;&lt;em&gt;BURP&lt;/em&gt;&lt;/span&gt;: pressure backwards,upwards and to the right.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;object height="373" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/LgSrtspeONg&amp;amp;rel=1&amp;amp;border=1"&gt;&lt;param name="wmode" value="transparent"&gt;&lt;embed src="http://www.youtube.com/v/LgSrtspeONg&amp;rel=1&amp;border=1" type="application/x-shockwave-flash" wmode="transparent" width="425" height="373"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#000000;"&gt;source:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.airwaycam.com/" target="_blank"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;Airwaycam.com&lt;/span&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-8450236713790947463?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/8450236713790947463/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=8450236713790947463' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8450236713790947463'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/8450236713790947463'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/sunday-february-3-2008-bimanual.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-4827185175091570031</id><published>2008-02-02T08:52:00.000-08:00</published><updated>2008-02-02T08:55:31.003-08:00</updated><title type='text'></title><content type='html'>&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday February 2, 2008&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Arterial line colonization and infection&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;In this month of Critical Care Medicine&lt;span style="font-size:78%;"&gt; 1&lt;/span&gt;, a study published from australia: Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. It was prospective 24-month cohort study.  331 arterial catheters were observed for 1,082 catheter days, and 618 central venous catheters for 4,040 catheter days.&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;All catheters were inserted by trained personnel under aseptic conditions, and management was standardized.&lt;/em&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results: &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#660000;"&gt;&lt;ul&gt;&lt;li&gt;&lt;/span&gt;The incidence per 1,000 catheter days of catheter-related bloodstream infection was 0.92 for arterial catheters and 2.23 for central venous catheters. &lt;/li&gt;&lt;li&gt;Arterial catheter colonization was not significantly different than that in central venous catheters. &lt;/li&gt;&lt;li&gt;Femoral arterial catheters were colonized more often than radial arterial catheters  &lt;/li&gt;&lt;li&gt;Colonization was significantly higher when the catheter was inserted in the operating theater or emergency department compared with the ICU !&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Conclusions:&lt;/span&gt; The incidence of catheter-related bloodstream infection from arterial catheters was low. However, both arterial catheter colonization and rates of catheter-related bloodstream infection were similar to those in concurrently sited and identically managed central venous catheters. &lt;em&gt;By inference, the arterial catheter should be accorded the same degree of importance as the central venous catheter as a potential source of sepsis.&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt; &lt;/p&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200802000-00003.htm;jsessionid=HjBTsGKbyN2cyQ143cNbwDPdGBQQJR75xKXXDGnfBmZVnGGRNrJ4!-1383090724!181195629!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters &lt;/span&gt;&lt;/a&gt;&lt;span style="color:#003333;"&gt;&lt;span style="font-size:78%;"&gt;- Critical Care Medicine. 36(2):397-402, February 2008&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-4827185175091570031?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/4827185175091570031/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=4827185175091570031' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/4827185175091570031'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/4827185175091570031'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/saturday-february-2-2008-arterial-line.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-9190982563308200791.post-4532991350991670304</id><published>2008-02-01T12:11:00.001-08:00</published><updated>2008-02-01T12:13:17.422-08:00</updated><title type='text'></title><content type='html'>&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday February 1, 2008&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Procedure video - IJ central line under ultrasound&lt;/span&gt;&lt;/strong&gt; &lt;strong&gt;&lt;span style="color:#990000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/1xsgE7ueaek&amp;amp;rel=" width="425" height="355" type="application/x-shockwave-flash" wmode="transparent"&gt;&lt;/embed&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;span style="color:#003333;"&gt;&lt;strong&gt;Related previous video:&lt;/strong&gt;&lt;/span&gt;&lt;a href="http://october-2007-icuroom.blogspot.com/2007_10_20_archive.html"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://october-2007-icuroom.blogspot.com/2007_10_20_archive.html" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Ultrasound windows for venous catheter placement&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/9190982563308200791-4532991350991670304?l=february2008-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://february2008-icuroom.blogspot.com/feeds/4532991350991670304/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=9190982563308200791&amp;postID=4532991350991670304' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/4532991350991670304'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/9190982563308200791/posts/default/4532991350991670304'/><link rel='alternate' type='text/html' href='http://february2008-icuroom.blogspot.com/2008/02/friday-february-1-2008-procedure-video_01.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
